ProCE Banner Series

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention

Join us for an interactive presentation where leading experts provide insight on management of elevated LDL-C levels to reduce ASCVD risk in the primary care setting. Learn about guideline recommendations and treatment options, including nonstatin therapies.

  AAPA
  | AMA
  | AANP
Credits Available

1.0

Who Should Attend

Primary care clinicians who are responsible for identifying patients that would benefit from LDL-C lowering and for initiating and intensifying primary and secondary prevention.

All Events

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention

Past Events

April

04

2023

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

April

20

2023

8:00 PM - 9:00 PM Eastern Time (ET)

Virtual

April

27

2023

6:00 PM - 7:00 PM Central Time (CT)

Virtual

May

10

2023

7:00 PM - 8:00 PM Eastern Time (ET)

Virtual

May

17

2023

12:00 PM - 1:00 PM Central Time (CT)

Virtual

May

24

2023

6:00 PM - 7:00 PM Pacific Time (PT)

Virtual

June

27

2023

7:00 PM - 8:00 PM Central Time (CT)

Virtual

June

28

2023

12:15 PM - 1:15 PM Central Time (CT)

Virtual

October

05

2023

6:00 PM - 7:00 PM Mountain Time (MT)

Virtual

Faculty

ProCE Banner Faculty
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

Medical Director
Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence Health System
Portland, Oregon

ProCE Banner Faculty
Viet Le, DMSc, PA-C, FACC, FAHA, HF-Cert

Associate Professor of Research, Preventive Cardiology PA
Intermountain Heart and Vascular Clinical Program
Intermountain Health, Canyons Region
Salt Lake City, Utah

ProCE Banner Faculty
Erin Michos, MD, MHS

Director of Women’s Cardiovascular Health Research
Associate Director of Preventive Cardiology
Associate Professor of Medicine & Epidemiology
Division of Cardiology
Johns Hopkins University School of Medicine
Baltimore, MD
Co-Editor in Chief, the American Journal of Preventive Cardiology

ProCE Banner Faculty
Margo B. Minissian, PhD, ACNP, FAHA, FNLA

Executive Director, Geri and Richard Brawerman Nursing Institute
Simms/ Mann Family Foundation Endowed Chair in Nurse Education,
Innovation and Research
Assistant Professor, Cardiology
Cedars-Sinai
Los Angeles, CA

Topics

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Program Overview
Join us for an interactive presentation where leading experts provide insight on management of elevated LDL-C levels to reduce ASCVD risk in the primary care setting. Learn about guideline recommendations and treatment options, including non-statin therapies.

Goal Statement
The goal of this program is to improve the knowledge and competence of primary care clinicians who manage patients with elevated LDL-C levels to reduce ASCVD risk.

Target Audience
The intended audience for this educational initiative is primary care clinicians who are responsible for identifying patients that would benefit from LDL-C lowering and for initiating and intensifying primary and secondary prevention.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess the efficacy, safety, and mechanism of action of non-statin agents approved to manage LDL-C levels.
  • Devise individualized evidence-based primary prevention plans for patients with elevated LDL-C levels.
  • Develop personalized strategies for secondary prevention for patients with elevated LDL-C levels using evidence-based guidelines.
  • Escalate treatment of elevated LDL-C levels by incorporating approved non-statin agents when statins alone do not achieve 2018 blood cholesterol guideline goals.

Accreditation

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

Physician Continuing Medical Education

Designation of Credit

USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 1.0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23036015. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Physician Assistant/Physician Associate Continuing Medical Education

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 4/4/2023 to 9/4/2024. AAPA reference number: CME-209116.

American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point and patient safety MOC credit in the American Board of Internal Medicine's (ABIM’s) Maintenance of Certification (MOC) program. It is USF Health’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants will earn MOC Points equivalent to the amount of CME credits claimed for the activity. USF Health will submit within 60 days the Diplomat’s MOC Points. No ABIM MOC Points certificates will be provided. Diplomats with questions regarding their Points, should contact USF Health at cpdsupport@usf.edu.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through USF Health's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

AAFP Credit Designation Statement
The AAFP has reviewed Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention, and deemed it acceptable for AAFP credit. Term of approval is from 04/04/2023 to 08/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

Disclosure of Conflicts of Interest 
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant financial relationships are listed below. All individuals not listed have no relevant financial relationships.

Acknowledgement

Jointly provided by USF Health and Rockpointe, in partnership with Clinical Care Options, LLC.

Supported by an educational grant from Novartis Pharmaceuticals Corporation.